Catalent's Indiana plant to make Novo's Wegovy weight-loss drug  - Reuters News Agency

Catalent’s Indiana plant to make Novo’s Wegovy weight-loss drug 

Reuters exclusively reported that Novo Nordisk has hired Thermo Fisher as its second contract manufacturer for its hugely popular weight-loss drug Wegovy. Novo Chief Financial Officer Karsten Munk Knudsen told Reuters in May the company had signed up a second contract manufacturer in the United States, but the identity of the company has not previously been reported. This was followed by another exclusive that Catalent’s plant in Bloomington, Indiana, will fill injection pens for Novo Nordisk’s  Wegovy as part of the two companies’ expanded supply agreement. Catalent’s shares briefly jumped on the news. 

Market Impact

Shares in Thermo jumped as much as 4% during New York trading on Wednesday. 

Article Tags
Topics of Interest: Health
Type: Reuters Best
Sectors: Pharmaceuticals & Healthcare
Regions: Americas
Countries: United States
Win Types: Exclusivity
Story Types: Exclusive / Scoop
Media Types: Text
Customer Impact: Significant National Story
Sign up for email updates
Sign up for email updates